Aandeel MVP MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
PDF-rapport : Medical Developments International Limited

Andere talen Medical Developments International Limited

Aandelen

MVP

AU000000MVP2

Beurs gesloten - Australian Stock Exchange
Andere beurzen
 06:10:51 04-12-2023 		Intraday-grafiek van Medical Developments International Limited Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,7550 AUD -3,21% -3,82% -48,99%
31/08 Transcript : Medical Developments International Limited, 2023 Earnings Call, Aug 31, 2023 CI
31/08 Medical Developments International Limited benoemt Russell Basser tot lid van de Raad van Bestuur met ingang van 1 september 2023 CI

Andere talen

Zoeken op
Ontgrendel al het nieuws: wees als eerste op de hoogte en reageer voordat de markten dat doen!
Gratis inschrijven
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX Emerging Companies Index
Medical Developments International Limited Appoints Russell Basser to the Board Effective 1 September 2023
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Medical Developments International Limited Announces Resignation of David Williams from Board
Medical Developments International Searches for Partner to Commercialize Pain Relief Product in the US
Medical Developments International Limited(ASX:MVP) dropped from S&P/ASX All Ordinaries Index
Medical Developments International Limited Reports Earnings Results for the Half Year Ended December 31, 2022
Medical Developments Stops Clinical Trial Preparation for Penthrox in China; Shares Rise 6%
Medical Developments International Limited Discontinues China Clinical Trials
Medical Developments International Limited Announces Resignation of Max Johnston as Director, Effective 27 October 2022
Medical Developments International Limited Provides Revenue Guidance for the Year 2023
Medical Developments International Limited(ASX:MVP) dropped from S&P Global BMI Index
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
Medical Developments International Limited Reports Earnings Results for the Full Year Ended June 30, 2022
Medical Developments International Sees Negative FY22 EBITDA, Launches Capital Hike
Medical Developments International Limited Provides Earnings Guidance for the Fiscal Year 2022 and Revenue Guidance for the Fiscal Year 2023
Medical Developments International Limited Appoints Tara Eaton as General Counsel and Company Secretary, Effective August 8, 2022
Medical Developments International Signs New Penthrox Licensing Agreement in Canada with New Partner Endo Ventures Limited
Medical Developments International Limited Announces Chief Financial Changes
Medical Developments International Limited Announces Board Changes
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel Artikel MarketScreener Analyse MarketScreener

Filters

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Aandeel Medical Developments International Limited - Australian Stock Exchange
  4. Nieuws Medical Developments International Limited
  5. Andere talen
Ontdek onze gratis inhoud om de beurs beter te leren begrijpen.
Gratis inschrijven
fermer
Etats-Unis

MarketScreener est aussi disponible en United States

Changer d'édition
Ik blijf hier.